Class Action Filed Against Maker Of Generic Anticholesterol Drug

, New Jersey Law Journal

   | 4 Comments

A putative class action has been lodged in New Jersey against the Princeton-based maker of the cholesterol-reducing drug Atorvastatin, which was found to be tainted with glass particles.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Continue to Lexis Advance®

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

  • RD Legal Funding

    Recalls are always bad news for companies and they are always used when plaintiffs pursue actions against those companies. Class action lawsuits are pretty common place in the pharmaceutical world. Especially when the drug that is being recalled can be very damaging to a person's health. This will take a long time to work through but it does not bode well for the pharmaceutical company given prior class actions.

  • RD Legal Funding

    Recalls are always bad news for companies and they are always used when plaintiffs pursue actions against those companies. Class action lawsuits are pretty common place in the pharmaceutical world. Especially when the drug that is being recalled can be very damaging to a person's health. This will take a long time to work through but it does not bode well for the pharmaceutical company given prior class actions.

  • ELois P. Clayton

    CHESTER MENTAL HEALTH CENTER(in Chester, Illinois), is LOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOG, OVERDUE, for being THOROUGHLY 'INTERNALLY INVESTIGATED', for the damages the PSYCH drugs, are doing to patients there(including to my brother David. P.);damaging there organs and effecting (negatively), their COGNITIVE abilities, because of the CONSTANT efforts of (for SURE, ONE), the "treatment teams'. FALSE REPORTS, submitted to the courts AND one in particular LCSW(Travis Nottmier), going into the courts BEHIND patients backs, getting judges to RENEW 'ORDERS", to continue to administer these PSYCH drugs, to patients there!

    NOTE: (As a family member), we have the RIGHT, to be PRESENT, for ANY, so-called, "eveluations", done to continue these acts of ABUSE and we were NOT informed (by way of letter OR by phone call) and this is a VIOLATION o f our lovedones, 'Human Rights'!

    PS: I(Mrs. Clayton;sister of patient David P.) can be contacted at ANY time, at (773)622-2906.

    PLEASE SEND HELP!



    Sign,

    Mrs. Clayton

  • me

    testing

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202580149574

Thank you!

This article's comments will be reviewed.